Investigational drug · Phase 3
JOINTSTEM
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Knee Osteoarthritis, Osteoarthritis, Knee.
Phase 3Last checked: Nov 19, 2026Latest source record: Aug 3, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
9
Any phase or sponsor naming "JOINTSTEM"
First trial start
2020
Apr 13, 2020
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "JOINTSTEM", any sponsor or status.
Conditions studied
As listed on its trial records.
- Knee Osteoarthritis
- Osteoarthritis, Knee
Approved drugs for the same conditions: Osteoarthritis
Largest trials
Live from ClinicalTrials.gov: studies naming "JOINTSTEM" as an intervention, largest first.
- A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of OsteoarthritisPivotal-lookingCompleted
R-BioIndustry
NCT03990805 · 260 participants · Start Jun 11, 2019 · Primary completion Dec 15, 2020
Drug: JOINTSTEM; saline · For: Degenerative Arthritis; Knee Osteoarthritis
Sites: Cheongju-si, South Korea; Daegu, South Korea; Jeonju, South Korea · 13 sites in all
- A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee OsteoarthritisPivotal-lookingActive, not recruiting
Nature Cell Co. Ltd.Industry
NCT04368806 · 173 participants · Start May 26, 2021 · Primary completion Aug 6, 2027
Drug: JointStem · For: Osteoarthritis, Knee
Sites: El Cajon, California; La Mesa, California; Napa, California · 9 sites in all
- Follow-up Study for Participants of Jointstem Phase 3 Clinical TrialPivotal-lookingActive, not recruiting
R-BioIndustry
NCT04427930 · 129 participants · Start Apr 13, 2020 · Primary completion Dec 23, 2026
Drug: JOINTSTEM · For: Knee Osteoarthritis
Sites: Daegu, South Korea; Seoul, South Korea · 4 sites in all
- A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of OsteoarthritisCompleted
Nature Cell Co. Ltd.Industry
NCT02674399 · 28 participants · Start Feb 16, 2016 · Primary completion Mar 12, 2018
Drug: JointStem; Synvisc-One · For: Osteoarthritis, Knee
Sites: Santa Monica, California; Walnut Creek, California
R-BioIndustry
NCT03000712 · 26 participants · Start Nov 2, 2016 · Primary completion May 22, 2020
Drug: Autologous Adipose Tissue derived MSCs 1x10^8cells/3ml · For: Degenerative Arthritis; Knee Osteoarthritis
Sites: Seoul, South Korea
- Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative ArthritisCompleted
R-BioIndustry
NCT02658344 · 24 participants · Start Jul 2015 · Primary completion Nov 2016
Drug: JOINTSTEM; Saline solution · For: Degenerative Arthritis; Knee Osteoarthritis
Sites: Seoul, South Korea · 2 sites in all
- Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM AdministrationStatus unknown
R-BioIndustry
NCT04821102 · 21 participants (planned) · Start Jul 1, 2023 · Primary completion Aug 1, 2024
Drug: JOINTSTEM; Saline · For: Degenerative Arthritis; Knee Arthritis
Sites: Yangsan, South Korea
- Follow-up Study for Participants of Jointstem Investigator Initiated Trial by ArthroscopyNot yet recruiting
R-BioIndustry
NCT04825730 · 14 participants (planned) · Start Dec 1, 2023 · Primary completion Dec 1, 2028
Drug: JOINTSTEM · For: Degenerative Arthritis; Knee Arthritis
R-BioIndustry
NCT03509025 · 11 participants · Start Feb 8, 2017 · Primary completion Dec 9, 2020
Drug: Jointstem · For: Knee Osteoarthritis
Sites: Seoul, South Korea · 2 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Household composition and extended kinship in Taiwan.
Freedman R, Moots B, Sun TH, et al. · Popul Stud (Camb) 1978
Also in development for Knee Osteoarthritis
- EcnoglutideXW003, VRB-101Phase 38 trials
Hangzhou Sciwind Biosciences Co., Ltd. · Obesity, Weight Management, OSA - Obstructive Sleep Apnea
- hUC-MSCsmesenchymal stem cells, MSCPhase 38 trials
Shenzhen Wingor Biotechnology Co., Ltd. · Knee Osteoarthritis, Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)
- Reference DrugNSAIDsPhase 32 trials
SANGMYUNG innovation · Retinal Vein Occlusion With Macular Edema, Knee Osteoarthritis
- PTP-01MOTYS, allogeneic human placental tissue particulatePhase 31 trial
Doron Therapeutics Inc. · Knee Osteoarthritis
- Human umbilical cord blood-derived mesenchymal stem cellsSMUP-IA-01, mid-dosePhase 22 trials
Medipost Co Ltd. · Knee Osteoarthritis, Bronchopulmonary Dysplasia, BPD
- TTAX03Phase 22 trials
BioTissue Holdings, Inc · Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis
- NCR100Phase 21 trial
Nuwacell Biotechnologies Co., Ltd. · Knee Osteoarthritis
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.